Pittsburgh startup @SwanNeuroTech, led by @kaceymarra
and newly appointed CEO and Adjunct Professor of Bioengineering Jeremy Kimmel, plans to commercialize biomaterial-based drug delivery platforms for peripheral nerve injuries. https://t.co/tKOnd7ynfu